At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Sleeve gastrectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Neuromuscular Blockade as a Determinant of Surgical Outcome and Post-operative Recovery, in Patients Undergoing Elective Laparoscopic Bariatric Surgery
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal·observational·Posted Nov 24, 2014·Updated Aug 19, 2015
In Brief
An observational study evaluating Sleeve gastrectomy for Bariatric Surgery Candidate. Completed, enrolled 50 participants.
Detailed Summary
The aim of the current observational study is to better assess the relationships between neuromuscular blockade and multiple surgical outcomes in patients undergoing elective laparoscopic bariatric surgery.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBariatric Surgery Candidate
Countries--
CollaboratorsMerck Sharp & Dohme LLC
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartSep 2014
Primary CompletionNov 2014
First PostedNov 2014
Study CompletionDec 2014
TodayJul 2026
First PostedNov 24, 2014
Enrollment StartSep 1, 2014
Primary CompletionNov 1, 2014
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 11.6 years ago
Interventions
Sleeve gastrectomyprocedure
Laparoscopic sleeve gastrectomy (LSG) is a restrictive procedure which consists in creating a narrow tube-like stomach, designed to decrease appetite by reducing the ability of the stomach to distend.